Abattis Announces Resignation of a Director
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/19/12 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX: FLU) announces the resignation of Mr. Yazan Al Homsi as a Director of the Company effective October 19, 2012. Mr. Mike Withrow, Chairman of the Board of the Directors on behalf of the Company, thanks Mr. Al Homsi for his service and contribution to the Company.
About Abattis Bioceuticals Corp.
Abattis Bioceutical Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients for use in BioPharma, Nutraceutical, Cosmetic and Animal Nutrition markets. The company has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at .
ON BEHALF OF THE BOARD
Michael Withrow, President & CEO
Neither the CNSX Exchange nor its regulations services accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Abattis Bioceuticals Corp.
Michael Withrow
President & CEO
778-710-9248
604-538-6658 (FAX)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.10.2012 - 22:56 Uhr
Sprache: Deutsch
News-ID 194399
Anzahl Zeichen: 0
contact information:
Town:
VANCOUVER, BRITISH COLUMBIA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 235 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Abattis Announces Resignation of a Director"
steht unter der journalistisch-redaktionellen Verantwortung von
Abattis Bioceuticals Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
